Literature DB >> 22433339

Vasomotor symptoms and lipid profiles in women transitioning through menopause.

Rebecca C Thurston1, Samar R El Khoudary, Kim Sutton-Tyrrell, Carolyn J Crandall, Ellen B Gold, Barbara Sternfeld, Hadine Joffe, Faith Selzer, Karen A Matthews.   

Abstract

OBJECTIVE: To examine associations between vasomotor symptoms and lipids over 8 years, controlling for other cardiovascular risk factors, estradiol, and follicle-stimulating hormone.
METHODS: Study of Women's Health Across the Nation participants (N=3,201), aged 42-52 years at entry, completed interviews on frequency of hot flushes and night sweats (none, 1-5 days, 6 days or more, in the past 2 weeks) physical measures (blood pressure, height, weight), and blood draws (low-density lipoprotein [LDL], high-density lipoprotein [HDL], apolipoprotein A-1, apolipoprotein B, lipoprotein[a], triglycerides, serum estradiol, follicle-stimulating hormone) yearly for 8 years. Relations between symptoms and lipids were examined in linear mixed models adjusting for cardiovascular risk factors, medications, and hormones.
RESULTS: Compared with no flushes, experiencing hot flushes was associated with significantly higher LDL (1-5 days: β [standard error]=1.48 [0.47], P<.01; 6 days or more: β [standard error]=2.13 [0.62], P<.001), HDL (1-5 days: β [standard error]=0.30 [0.18]; 6 days or more: β [standard error]=0.77 [0.24], P<.01), apolipoprotein A-1 (1-5 days: β [standard error]=0.92 [0.47], P<.10; 6 days or more: β [standard error]=1.97 [0.62], P<.01), apolipoprotein B (1-5 days: β [standard error]=1.41 [0.41], P<.001; 6 days or more: β [standard error]=2.51 [0.54], P<.001), and triglycerides (1-5 days: percent change [95% confidence interval]=2.91 [1.41-4.43], P<.001; 6 days or more: percent change [95% confidence interval[=5.90 [3.86-7.97], P<.001) in multivariable models. Findings largely persisted adjusting for hormones. Estimated mean differences in lipid levels between hot flushes 6 days or more compared with no days ranged from less than 1 (for HDL) to 10 mg/dL (for triglycerides). Night sweats were similar. Associations were strongest for lean women.
CONCLUSION: Vasomotor symptoms were associated with higher LDL, HDL, apolipoprotein A-1, apolipoprotein B, and triglycerides. Lipids should be considered in links between hot flushes and cardiovascular risk. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22433339      PMCID: PMC3343636          DOI: 10.1097/AOG.0b013e31824a09ec

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  27 in total

1.  Ultrasensitive semiautomated chemiluminescent immunoassay for estradiol.

Authors:  Barry G England; George H Parsons; Russell M Possley; Daniel S McConnell; A Rees Midgley
Journal:  Clin Chem       Date:  2002-09       Impact factor: 8.327

2.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation.

Authors:  Rebecca C Thurston; Samar R El Khoudary; Kim Sutton-Tyrrell; Carolyn J Crandall; Ellen Gold; Barbara Sternfeld; Faith Selzer; Karen A Matthews
Journal:  Menopause       Date:  2011-10       Impact factor: 2.953

5.  Vasomotor symptoms and cardiovascular events in postmenopausal women.

Authors:  Emily D Szmuilowicz; JoAnn E Manson; Jacques E Rossouw; Barbara V Howard; Karen L Margolis; Nancy C Greep; Robert G Brzyski; Marcia L Stefanick; Mary Jo O'Sullivan; Chunyuan Wu; Matthew Allison; Diederick E Grobbee; Karen C Johnson; Judith K Ockene; Beatriz L Rodriguez; Gloria E Sarto; Mara Z Vitolins; Ellen W Seely
Journal:  Menopause       Date:  2011-06       Impact factor: 2.953

Review 6.  The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements.

Authors:  G L Myers; G R Cooper; C L Winn; S J Smith
Journal:  Clin Lab Med       Date:  1989-03       Impact factor: 1.935

7.  Evaluation of the kaiser physical activity survey in women.

Authors:  B E Ainsworth; B Sternfeld; M T Richardson; K Jackson
Journal:  Med Sci Sports Exerc       Date:  2000-07       Impact factor: 5.411

8.  Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women.

Authors:  Genevieve A Woodard; Maria M Brooks; Emma Barinas-Mitchell; Rachel H Mackey; Karen A Matthews; Kim Sutton-Tyrrell
Journal:  Menopause       Date:  2011-04       Impact factor: 2.953

9.  Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.

Authors:  Bela F Asztalos; Dorothea Collins; L Adrienne Cupples; Serkalem Demissie; Katalin V Horvath; Hanna E Bloomfield; Sander J Robins; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-25       Impact factor: 8.311

Review 10.  Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment.

Authors:  Heather S Lett; James A Blumenthal; Michael A Babyak; Andrew Sherwood; Timothy Strauman; Clive Robins; Mark F Newman
Journal:  Psychosom Med       Date:  2004 May-Jun       Impact factor: 4.312

View more
  33 in total

1.  Changes in heart rate variability during vasomotor symptoms among midlife women.

Authors:  Rebecca C Thurston; Karen A Matthews; Yuefang Chang; Nanette Santoro; Emma Barinas-Mitchell; Roland von Känel; Doug P Landsittel; J Richard Jennings
Journal:  Menopause       Date:  2016-05       Impact factor: 2.953

2.  Predictors of vasomotor symptoms among breast cancer survivors.

Authors:  Katherine W Reeves; Michael Pennell; Randi E Foraker; Carolyn J Crandall; Marcia Stefanick; Electra D Paskett
Journal:  J Cancer Surviv       Date:  2018-02-09       Impact factor: 4.442

3.  Measuring hot flash phenomenonology using ambulatory prospective digital diaries.

Authors:  William I Fisher; Rebecca C Thurston
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

4.  Duration of menopausal vasomotor symptoms over the menopause transition.

Authors:  Nancy E Avis; Sybil L Crawford; Gail Greendale; Joyce T Bromberger; Susan A Everson-Rose; Ellen B Gold; Rachel Hess; Hadine Joffe; Howard M Kravitz; Ping G Tepper; Rebecca C Thurston
Journal:  JAMA Intern Med       Date:  2015-04       Impact factor: 21.873

5.  Menopausal hot flashes and white matter hyperintensities.

Authors:  Rebecca C Thurston; Howard J Aizenstein; Carol A Derby; Ervin Sejdić; Pauline M Maki
Journal:  Menopause       Date:  2016-01       Impact factor: 2.953

Review 6.  Vasomotor symptoms: natural history, physiology, and links with cardiovascular health.

Authors:  R C Thurston
Journal:  Climacteric       Date:  2018-02-02       Impact factor: 3.005

7.  Trajectories of Vasomotor Symptoms and Carotid Intima Media Thickness in the Study of Women's Health Across the Nation.

Authors:  Rebecca C Thurston; Samar R El Khoudary; Ping Guo Tepper; Elizabeth A Jackson; Hadine Joffe; Hsiang-Yu Chen; Karen A Matthews
Journal:  Stroke       Date:  2015-11-17       Impact factor: 7.914

8.  Vasomotor symptoms and lipids/lipoprotein subclass metrics in midlife women: Does level of endogenous estradiol matter? The SWAN HDL Ancillary Study.

Authors:  Alexis Nasr; Karen A Matthews; Maria M Brooks; Daniel S McConnell; Trevor J Orchard; Jeffrey Billheimer; Daniel J Rader; Samar R El Khoudary
Journal:  J Clin Lipidol       Date:  2020-07-08       Impact factor: 4.766

Review 9.  Menopause, atherosclerosis, and coronary artery disease.

Authors:  Elizabeth Barrett-Connor
Journal:  Curr Opin Pharmacol       Date:  2013-01-23       Impact factor: 5.547

10.  Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Rebecca C Thurston; B Delia Johnson; Chrisandra L Shufelt; Glenn D Braunstein; Sarah L Berga; Frank Z Stanczyk; Carl J Pepine; Vera Bittner; Steven E Reis; Diane V Thompson; Sheryl F Kelsey; George Sopko; C Noel Bairey Merz
Journal:  Menopause       Date:  2017-02       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.